Last reviewed · How we verify
NS infusion
NS infusion is a normal saline (0.9% sodium chloride) intravenous fluid that restores intravascular volume and maintains electrolyte balance.
NS infusion is a normal saline (0.9% sodium chloride) intravenous fluid that restores intravascular volume and maintains electrolyte balance. Used for Dehydration and hypovolemia, Perioperative fluid maintenance, Vehicle for intravenous medication administration.
At a glance
| Generic name | NS infusion |
|---|---|
| Sponsor | Seoul National University Hospital |
| Drug class | Crystalloid fluid / Electrolyte replacement |
| Modality | Small molecule |
| Therapeutic area | Supportive Care / Fluid Management |
| Phase | FDA-approved |
Mechanism of action
Normal saline is an isotonic crystalloid solution containing sodium and chloride ions in physiologic concentrations. It is administered intravenously to treat hypovolemia, dehydration, and electrolyte imbalances by expanding the extracellular fluid compartment and maintaining hemodynamic stability. NS is a fundamental supportive therapy rather than a disease-modifying agent.
Approved indications
- Hypovolemia and dehydration
- Perioperative fluid maintenance
- Electrolyte and acid-base balance support
- Vehicle for intravenous medication delivery
Common side effects
- Hyperchloremic acidosis
- Fluid overload / pulmonary edema (with excessive administration)
- Hyponatremia (with prolonged use in certain settings)
Key clinical trials
- Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma (PHASE2)
- Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors (PHASE2)
- Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults (PHASE2)
- Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue Sarcoma (PHASE1)
- Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer (PHASE2)
- Magnesium Sulfate Infusion on Postoperative Pain in Lumbar Surgery (NA)
- Perioperative Multimodal Analgesia Protocol for Supratentorial Craniotomy (NA)
- Dexmedetomidine on Brain Injury Patients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- NS infusion CI brief — competitive landscape report
- NS infusion updates RSS · CI watch RSS
- Seoul National University Hospital portfolio CI